MRNS Historical Earnings image   This MRNS historical earnings page last updated 11/14/2024
MRNS Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202411/12/20240.01B
Q2 20248/13/20240.01B
Q1 20245/8/20240.01B
Q4 20233/5/20240.01B
Q3 202311/7/20230.01B
Q2 20238/10/20230.01B
Q1 20235/11/20230.01B
Q4 20223/7/20230.01B
Q3 202211/7/20220.00B
Q2 20228/11/20220.00B
Q1 20225/12/20220.01B
Q4 20213/21/20220.00B
Q3 202111/9/20210.01B
Q2 20218/10/20210.00B
Q1 20215/17/20210.00B
Q4 20203/9/20210.00B
Q3 202011/9/20200.00B
Q2 20208/6/2020NA
Q1 20205/4/2020NA
Q4 20193/16/2020NA
Q3 201911/6/2019NA
Q2 20198/8/2019NA
Q1 20195/1/2019NA
Q4 20183/11/2019NA
Q3 201810/29/2018NA
Q2 20188/2/2018NA
Q1 20185/2/2018NA
Q4 20173/6/2018NA
Q3 201710/31/2017NA
Q2 20178/1/2017NA
Q1 20175/1/2017NA
Q4 20163/13/2017NA
Q3 201611/3/2016NA
Q2 20168/8/2016NA
Q1 20165/2/2016NA
Q4 20153/7/2016NA
Q3 201510/29/2015NA
Q2 20158/4/2015NA
Q1 20155/11/2015NA
Q4 20143/12/2015NA
Q3 201411/13/2014NA
MRNS Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202411/12/2024-0.420
Q2 20248/13/2024-0.630
Q1 20245/8/2024-0.680
Q4 20233/5/2024-0.740
Q3 202311/7/2023-0.610
Q2 20238/10/2023-0.610
Q1 20235/11/2023-0.670
Q4 20223/7/2023-0.760
Q3 202211/7/2022-0.940
Q2 20228/11/2022-1.060
Q1 20225/12/2022-0.520
Q4 20213/21/2022-0.770
Q3 202111/9/2021-0.530
Q2 20218/10/2021-0.650
Q1 20215/17/2021-0.740
Q4 20203/9/2021-0.550
Q3 202011/9/2020-0.510
Q2 20208/6/2020-0.640
Q1 20205/4/2020-1.280
Q4 20193/16/2020-1.000
Q3 201911/6/2019-1.040
Q2 20198/8/2019-0.960
Q1 20195/1/2019-0.960
Q4 20183/11/2019-0.960
Q3 201810/29/2018-1.080
Q2 20188/2/2018-0.960
Q1 20185/2/2018-0.600
Q4 20173/6/2018-0.720
Q3 201710/31/2017-0.600
Q2 20178/1/2017-0.840
Q1 20175/1/2017-1.040
Q4 20163/13/2017-1.240
Q3 201611/3/2016-1.320
Q2 20168/8/2016-1.840
Q1 20165/2/2016-1.480
Q4 20153/7/2016-1.800
Q3 201510/29/2015-1.400
Q2 20158/4/2015-1.480
Q1 20155/11/2015-2.000
Q4 20143/12/20152.480
Q3 201411/13/2014-0.880
Quotes delayed 20 minutes

Email EnvelopeFree MRNS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Marinus Pharma (MRNS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MRSN Historical Earnings
MRTX Historical Earnings
MRVI Historical Earnings
MSON Historical Earnings
MTCR Historical Earnings
MTEM Historical Earnings
MXCT Historical Earnings
MYGN Historical Earnings
MYMD Historical Earnings
NAOV Historical Earnings
What was the record high MRNS historical earnings result?
In terms of earnings or revenue, what is the best MRNS historical earnings result that Marinus Pharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest MRNS historical earnings result was set in Q4 2014, when Marinus Pharma posted results of 2.480/share. The most successful revenue quarter within our data set was Q1 2022 when Marinus Pharma reported revenue of 0.01B.

What was the lowest Marinus Pharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest MRNS has reported, and when?

✔️Accepted answer: Within our data set, the lowest MRNS historical earnings result was set in Q1 2015, when Marinus Pharma posted results of -2.000/share. The smallest revenue quarter within our data set was Q2 2020 when Marinus Pharma reported revenue of NA.

On this page we presented the MRNS historical earnings date information for Marinus Pharma. Reviewing that MRNS Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2014, when MRNS posted gaap of 2.480/share. Meanwhile the lowest MRNS historical earnings result was in Q1 2015, when MRNS posted gaap of -2.000/share. Moving to Marinus Pharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2022 when MRNS reported 0.01B in revenue, while the smallest revenue quarter was Q2 2020 when MRNS reported NA in revenue.

For self directed investors doing their due diligence on MRNS or any other given stock, their research can benefit from looking into all of the Marinus Pharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Marinus Pharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for MRNS. Thanks for visiting, and the next time you need to research MRNS historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding NVDD, QELL YTD Return, Top Ten Hedge Funds Holding INTF.

 

MRNS Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.